Tracon Pharmaceuticals, Inc. 4
4 · Tracon Pharmaceuticals, Inc. · Filed Feb 5, 2015
Insider Transaction Report
Form 4
Twiford J Rainer
Director
Transactions
- Conversion
Series A Redeemable Convertible Preferred Stock
2015-02-04−1,610,150→ 0 total(indirect: By LLC)→ Common Stock (416,059 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2015-02-04−934,579→ 0 total(indirect: By LLC)→ Common Stock (241,493 underlying) - Conversion
Common Stock
2015-02-04+657,552→ 657,552 total(indirect: By LLC)
Holdings
- 437,210(indirect: By LLC)
Common Stock
- 93,460(indirect: By LLC)
Common Stock
- 10,029(indirect: By LLC)
Common Stock
- 49,380(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]In connection with the Issuer's initial public offering, the preferred stock automatically converted into shares of the Issuer's common stock at the rate of 1 share of common stock for each 3.87 shares of preferred stock. The preferred stock had no expiration date.
- [F2]The Reporting Person has voting and dispositive power over these shares and disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- [F3]The reporting person's spouse has voting and investment power with respect to the shares held by MCT Investments, LLC.